IGF-1 splice variant
Also known as: Long R3 IGF-1 · IGF-1LR3
The essentials at a glance
Linked to growth, metabolic and muscle themes; as an unapproved analogue it lacks confirmed safety and benefit.
Distinction: IGF-1 LR3 is a modified, longer-acting analogue of endogenous IGF-1, not growth hormone itself.
Prohibited or covered under WADA rules in competitive sport.
Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.
Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.
Research questions
This studies how a locally produced tissue variant of the growth factor IGF-1 might be involved in muscle cell repair, similar to a regional rather than a body-wide response. Cell growth and repair markers are measured in lab models.
Researchers study how a substance amplifies the natural hormone chain from brain to pituitary to growth hormone, rather than supplying growth hormone directly. Hormone levels over time and muscle or fat mass are measured.
This studies direct administration of recombinant growth hormone for a confirmed deficiency, similar to replacing a missing substance the body normally produces. Growth, body composition, and hormone levels are measured in clinical studies.
Simple example
Think of it like a component still being tested in a development workshop, not yet cleared for general use.
Research status means efficacy, dosing, and safety in humans are not yet conclusively established.
Community themes
Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.
Here, muscle growth, strength gains, and recovery times are compared between different growth and repair peptides, often based on personal training logs. Vendor and user claims about muscle gains are anecdotal experience, not controlled study results.
Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.
The use of performance-enhancing peptides in sport is discussed, including experiences with competition testing and regulatory ban lists. Personal experience does not establish efficacy or safety and does not replace official rule checks.
Why individual profiles do not contain mixing instructions
Reconstitution depends on the exact product, label, identity, concentration, sterility and stability. Arithmetic examples appear only in the separately labelled community area and are not recommendations.
Reconstitution & quantitiesOpen basics, units and sourcesUse & mixingEvidence boundary
As an unapproved analogue it lacks confirmed safety and benefit.
No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.
Primary sources
Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.
